Sickle Cell Disease

Resource Center

Pearls of Wisdom

Research Summaries

Research Summary

Research Summary

Active Smoking Linked to Sickle Cell Retinopathy Progression

10/05/2026

Ashton L. Stahl

The study’s strong association between active smoking at proliferative sickle retinopathy (PSR) diagnosis and the condition’s subsequent progression spurred the authors to support smoking cessation and...

10/05/2026

Timelines

Notable FDA Approvals in July

07/27/2026

July 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...

07/27/2026

FDA Approval

FDA Expands Casgevy Approval to Children Aged 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent β-Thalassemia

07/21/2026

Anthony Calabro, MA

The FDA expanded approval of exagamglogene autotemcel (Casgevy) for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent β-thalassemia. ...

07/21/2026

Conference Coverage

Conference Coverage

Comorbid COPD Increases Readmission Risk After Acute Chest Syndrome in Adults with Sickle Cell Disease

12/08/2025

Anthony Calabro, MA

A new national analysis provides clinicians with evidence on how chronic obstructive pulmonary disease affects post-discharge outcomes in adults with sickle cell disease hospitalized for acute chest...

12/08/2025

Conference Coverage

Conference Coverage

Low Adherence to Timely Opioid Administration for Acute Sickle Cell Disease Pain

12/07/2025

Ashton L. Stahl

A new multicenter analysis presented at the 67th American Society of Hematology (ASH) Annual Meeting evaluates how often emergency departments meet national guidelines for timely opioid administration in...

12/07/2025

October 2026

Current Issue

October 2026